This company seems to have been delisted
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Biocept
BIOC
£0.34
Share price
0.00%
Change (1 day)
-95.83%
Change (1 year)
Categories
Biocept (BIOC) - P/B ratio
P/B ratio as of March 2025 : 3.94
According to Biocept
's latest financial reports the company has a price-to-book ratio of -0.332381.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Biocept - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.94 | 285.92% |
| 2022-12-31 | 1.02 | -37.27% |
| 2021-12-31 | 1.63 | -35.21% |
| 2020-12-31 | 2.51 | 79.62% |
| 2019-12-31 | 1.40 | 6.81% |
| 2018-12-31 | 1.31 | -93.05% |
| 2017-12-31 | 18.8 | -8.51% |
| 2016-12-31 | 20.6 | 180.11% |
| 2015-12-31 | 7.35 | -114.69% |
| 2014-12-31 | -50.0 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 3.53 | -10.33% | 🇺🇸 USA |
 | 1.27 | -67.82% | 🇺🇸 USA |
 | 2.23 | -43.30% | 🇺🇸 USA |